Optiver Holding’s Exelixis EXEL Stock Holding History

Optiver Holding’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,764	Closed	-$40K	–	408
2022 Q1	$40K	Buy	+1,764	New	+$34.5K	﹤0.01%	320

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Optiver Holding's EXEL Position: Q2 2022 in Review

Optiver Holding sold out of Exelixis (EXEL) in Q2 2022, closing a stake of 1,764 shares — an estimated $40K sold.

Optiver Holding first reported a position in EXEL in Q1 2022 and held it in 1 quarter. The position peaked at $40K in Q1 2022. 373 funds tracked by Wall St. Rank hold EXEL as of Q2 2022.

Optiver Holding reported no remaining Exelixis position as of Q2 2022 after selling out during the quarter.
Optiver Holding sold 1,764 Exelixis shares in Q2 2022, an estimated $40K.
Optiver Holding first reported a position in Exelixis in Q1 2022 and held it in 1 quarter.
Optiver Holding's Exelixis position peaked at $40K in Q1 2022.
373 funds tracked by Wall St. Rank held Exelixis as of Q2 2022.

Based on Optiver Holding's 13F filing for Q2 2022, filed 10 Aug 2022.